-transparent.png){kind=logo}
Results with a new anti-angina molecule (nifedipine: Adalat) in the long-term management of 28 patients with ischaemic heart disease are presented. The effectiveness of the drug was judged outstanding on the strength of its reduction of angina outstanding on the strength of its reduction of angina crises and consumption of NTG beads. Non side-effects were noted.
Related Publications
M Cafiero, and
P Sensale, and
G Buono
January 1978,
Giornale di clinica medica,
M Cafiero, and
P Sensale, and
G Buono
January 1978,
Bollettino della Societa italiana di cardiologia,
M Cafiero, and
P Sensale, and
G Buono
January 1978,
Archivos del Instituto de Cardiologia de Mexico,
M Cafiero, and
P Sensale, and
G Buono
January 1982,
Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
M Cafiero, and
P Sensale, and
G Buono
January 1978,
Bollettino della Societa italiana di cardiologia,
M Cafiero, and
P Sensale, and
G Buono
January 1978,
Bollettino della Societa italiana di cardiologia,
M Cafiero, and
P Sensale, and
G Buono
January 1978,
Bollettino della Societa italiana di cardiologia,
M Cafiero, and
P Sensale, and
G Buono
January 1972,
Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
M Cafiero, and
P Sensale, and
G Buono
March 1988,
Revista espanola de cardiologia,
M Cafiero, and
P Sensale, and
G Buono
October 1980,
Minerva medica,
